Statistics for REVOLUTION Medicines (id:7520 RVMD)

Valuation metrics

Market cap

9.27B

Enterprise value

7.81B

Trailing P/E (ttm)

-14.70

Forward P/E

-13.61

PEG ratio

-13.61

Price/Sales (ttm)

12.50K

Price/Book (mrq)

5.90

Enterprise Value/Revenue

10.53K

Enterprise Value/EBITDA

-12.57

Overview

Shares outstanding

168.22M

Float

154.80M

Shares short

18.14M

% Held by insiders

0.02%

% Held by institutions

1.04%

Average volume (10 days)

1.75M

Average volume (90 days)

Price summary

52-Week low

20.98

52-Week high

62.40

52-Week change

61.78%

Beta

1.40

50-Day moving average

49.14

200-Day moving average

40.46

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

-84,595.28%

Operational effectiveness

Return on assets

-28.56%

Return on equity

-47.18%

Income statement

Revenue (ttm)

0.00

Revenue per share (ttm)

0.00

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-621,556,992.00

Net income to common (ttm)

-567,060,992.00

Diluted EPS (ttm)

-3.66

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

1.55B

Total cash per share (mrq)

9.21

Total debt (mrq)

86.71M

Total Debt/Equity (mrq)

5.54

Current ratio (mrq)

1.42K%

Book value per share (mrq)

9.34

Cash flow

Cash flow statement

-539,708,992.00

Levered free cash flow (LFCF)

-306,128,000.00